These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 21315122)

  • 1. Nanoparticles and microparticles for skin drug delivery.
    Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS
    Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanoparticles for dermal drug delivery.
    Kakadia PG; Conway BR
    Curr Pharm Des; 2015; 21(20):2823-9. PubMed ID: 25925115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles.
    Labouta HI; Kraus T; El-Khordagui LK; Schneider M
    Int J Pharm; 2011 Jul; 413(1-2):279-82. PubMed ID: 21515347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles for improved topical application of drugs for skin diseases.
    Schäfer-Korting M; Mehnert W; Korting HC
    Adv Drug Deliv Rev; 2007 Jul; 59(6):427-43. PubMed ID: 17544165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
    Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
    Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid vesicles and other colloids as drug carriers on the skin.
    Cevc G
    Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery with topically applied nanoparticles: science fiction or reality.
    Lademann J; Richter H; Meinke MC; Lange-Asschenfeldt B; Antoniou C; Mak WC; Renneberg R; Sterry W; Patzelt A
    Skin Pharmacol Physiol; 2013; 26(4-6):227-33. PubMed ID: 23921109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
    Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
    Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin.
    Jensen LB; Petersson K; Nielsen HM
    Eur J Pharm Biopharm; 2011 Sep; 79(1):68-75. PubMed ID: 21664463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
    Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
    J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles and microparticles as vaccine-delivery systems.
    Singh M; Chakrapani A; O'Hagan D
    Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles--an efficient carrier for drug delivery into the hair follicles.
    Lademann J; Richter H; Teichmann A; Otberg N; Blume-Peytavi U; Luengo J; Weiss B; Schaefer UF; Lehr CM; Wepf R; Sterry W
    Eur J Pharm Biopharm; 2007 May; 66(2):159-64. PubMed ID: 17169540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism and determinants of nanoparticle penetration through human skin.
    Labouta HI; el-Khordagui LK; Kraus T; Schneider M
    Nanoscale; 2011 Dec; 3(12):4989-99. PubMed ID: 22064944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil.
    Padois K; Cantiéni C; Bertholle V; Bardel C; Pirot F; Falson F
    Int J Pharm; 2011 Sep; 416(1):300-4. PubMed ID: 21704140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A facile construction strategy of stable lipid nanoparticles for drug delivery using a hydrogel-thickened microemulsion system.
    Chen H; Xiao L; Du D; Mou D; Xu H; Yang X
    Nanotechnology; 2010 Jan; 21(1):015101. PubMed ID: 19946154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption.
    Filipe P; Silva JN; Silva R; Cirne de Castro JL; Marques Gomes M; Alves LC; Santus R; Pinheiro T
    Skin Pharmacol Physiol; 2009; 22(5):266-75. PubMed ID: 19690452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocarrier-based topical drug delivery for the treatment of skin diseases.
    Gupta M; Agrawal U; Vyas SP
    Expert Opin Drug Deliv; 2012 Jul; 9(7):783-804. PubMed ID: 22559240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of nanoparticles and an associated lipophilic permeant following topical application to the skin.
    Wu X; Price GJ; Guy RH
    Mol Pharm; 2009; 6(5):1441-8. PubMed ID: 19630400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric micelle nanocarriers for the cutaneous delivery of tacrolimus: a targeted approach for the treatment of psoriasis.
    Lapteva M; Mondon K; Möller M; Gurny R; Kalia YN
    Mol Pharm; 2014 Sep; 11(9):2989-3001. PubMed ID: 25057896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.